Screener
Kymera Therapeutics KYMR Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The source filing: Kymera Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333849
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Other current liabilities | 236 | 242 |
| Total current liabilities | $71,326 | $83,212 |
| Non-current liabilities | ||
| Deferred revenue, net of current portion | — | 11,440 |
| Operating lease liabilities, net of current portion | 64,022 | 67,034 |
| Finance lease liabilities, net of current portion | 840 | 1,462 |
| Total liabilities | $136,188 | $163,148 |
| Stockholders’ equity: |
Item 1. Financial Statements.
FAQ
- What is Kymera Therapeutics's contract liabilities, non-current?
- Kymera Therapeutics (KYMR) reported contract liabilities, non-current of $0 in Q2 2026.
- What is the long-term trend for Kymera Therapeutics's contract liabilities, non-current?
- Over 5 years (2020 to 2025), Kymera Therapeutics's contract liabilities, non-current has grown at a -31.9% compound annual growth rate (CAGR), from $77.84M to $11.44M.
- What does contract liabilities, non-current mean?
- Obligation to transfer goods or services for which payment has been received, expected to be satisfied beyond one year.
Ask your AI about Kymera Therapeutics's contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude